Loading...

Slow Formulary Coverage Will Hamper Diabetes Reach Yet Enable Rebound

Published
10 May 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-27.3%
7D
-1.8%

Author's Valuation

US$837.9% undervalued intrinsic discount

AnalystLowTarget Fair Value